We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Bayer and Onyx Begin Enrollment in Storm Trial Studying Nexavar as Adjuvant Therapy for Patients with Liver Cancer

News   Aug 26, 2008

 
Bayer and Onyx Begin Enrollment in Storm Trial Studying Nexavar as Adjuvant Therapy for Patients with Liver Cancer
 
 
 

RELATED ARTICLES

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

Tracking Gut-derived Metabolites

News

Ten new research awards totaling nearly $4 million will allow researchers to study possible links between gut microflora and the transformation of dietary compounds into metabolites.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE